Article Details

Ready to square off with Pfizer in next-gen pneumococcal vaccines, a Merck exec says ...

Retrieved on: 2021-02-25 15:11:15

Tags for this article:

Click the tags to see associated articles and topics

Ready to square off with Pfizer in next-gen pneumococcal vaccines, a Merck exec says .... View article details on hiswai:

Excerpt

Both Merck's 15-valent pneumococcal conjugate vaccine and Pfizer's 20-valent shot have scored FDA priority reviews, setting them up for decisions in ...

Article found on: www.fiercepharma.com

View Original Article

This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.

Sign Up